Sex-specific role of androgen signaling in neuroendocrine-behavior interface
Project Number5R01HD106962-02
Former Number1R01HD106962-01
Contact PI/Project LeaderELIAS, CAROL FUZETI
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
Abstract/Project Summary
Disorders of androgens imbalance are highly prevalent in both sexes. Hyperandrogenic females experience
reproductive dysfunction, whereas low androgens disrupt sexual behavior, decrease libido and fertility, and
induce fatigue, depression, and bone loss in both sexes. Studies using mouse genetics (e.g., androgen
receptor knockout) replicate male reproductive dysfunctions caused by low androgens or AR insensitivity. In
females, AR insensitivity results in subfertility, with disrupted uterine morphology, fewer corpora lutea,
abnormal estrous cycles and accelerated reproductive senescence. AR is highly expressed in multiple brain
sites, but the role of specific neuronal circuitry or individual subpopulations has not been demonstrated, and
the causes and mechanisms underlying disorders of androgen imbalance mediated by brain AR remain
unknown. This is particularly important in androgens abuse and for gender dysphoric/gender incongruent
individuals which seek gender-affirming hormone treatment. The consequences and potential effects of
supraphysiologic androgens on brain function are largely unknown. Our main goal in this application is to
determine the role of direct androgen actions in highly interconnected brain sites that express low or virtually
no aromatase, i.e., neuronal circuitry not susceptible to estrogen actions following site-specific conversion of
testosterone to estradiol. The circuit is comprised of the posterior nucleus of the amygdala (PA) and the ventral
premammillary nucleus (PMv). The PA relays conspecific olfactory signals and is highly relevant for human’s
physical and sexual health. Functional neuroimaging studies, neurological insults or brain lesions have shown
that the PA has a critical role in sexual drive, hyper- or hyposexuality, and sexual disorders (e.g., paraphilias)
in a sex specific mode. The PA densely projects to the PMv which has a fundamental role in the modulation of
the neuroendocrine reproductive axis. Our goal is to determine the role of AR in specific brain nuclei of male
and female mice focused on the integration of environmental signals, sexual behavior, and neuroendocrine
control. We hypothesize that AR in PA neurons is necessary for sex recognition, and sexual arousal, and that
PA inputs to PMv AR neurons connect sexual arousal to neuroendocrine (gonadotropins) and behavioral
responses. We will employ Cre-loxP and FlpO-Frt approaches to conditionally delete Ar in these neuronal
populations, viral vectors, TeTox and DREADDs technology to remotely silence or activate AR expressing
neurons, different steroids milieu, and molecular mapping of chemically defined AR neurons in two
independent aims. Our findings will open new opportunities for a better understanding of the mechanisms
associated with the pathophysiology of altered levels of androgens mediated by neuronal AR. Unraveling the
role of AR in defined neuronal circuitry is an essential step toward the prevention of adverse health
consequences caused by hyper- or hypoandrogenism in a sex-specific manner.
Public Health Relevance Statement
Project Narrative
High levels of androgens in women is associated with disrupted neuroendocrine function and infertility, whereas
low androgens decrease sexual behavior and fertility, and induce fatigue, depression, and bone loss in both
sexes. High density of androgen receptors is observed in the brain, but their function in specific neuronal
populations is unknown. We will use genetic mouse models and molecular tools to determine the role of
androgens receptor in chemically defined subsets of neurons and the underlying mechanisms associated with
reproductive deficits caused by altered androgens signaling in the brain.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-August-2023
Project End Date
31-May-2028
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$412,349
Direct Costs
$264,326
Indirect Costs
$148,023
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$412,349
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD106962-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD106962-02
Patents
No Patents information available for 5R01HD106962-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD106962-02
Clinical Studies
No Clinical Studies information available for 5R01HD106962-02
News and More
Related News Releases
No news release information available for 5R01HD106962-02
History
No Historical information available for 5R01HD106962-02
Similar Projects
No Similar Projects information available for 5R01HD106962-02